Transaktionen anzeigen
Healthcare

Laboratorios Saval S.A. has acquired a pharmeceutical processing plant

Laboratorios Saval S.A. has acquired a pharmeceutical processing plant in Costa Rica from Laboratorios Stein S.A.

Laboratorios Saval is a Chilean company with more than 80 years of history. It began its history in Spain in the 1930s and today, has a presence in more than 14 countries. The company manufactures and distributes pharmaceuticals in the areas of infectious diseases, ophthalmology, immunology and oncology, gastroenterology, bronchopulmonary, cardiology, psychiatry and rheumatology.

Laboratorios Stein is a leading company in Latin America in the commercialization and distribution of highly complex pharmaceutical products including innovative products, biosimilars and complex generics.

Oaklins’ team in Chile acted as financial advisor to Laboratorios Saval in this transaction.

Art der transaktion
BETEILIGTE PARTEIEN

Sprechen Sie mit dem Deal-Team

Felipe Porzio

Executive Board Member
Santiago, Chile
Oaklins LarrainVial

Agustin Achondo

Director
Santiago, Chile
Oaklins LarrainVial

Alberto Parot

Analyst
Santiago, Chile
Oaklins LarrainVial

Transaktionen

CARSO Group has acquired a majority stake in AQCF Group
Private Equity | Business Support Services | Healthcare

CARSO Group has acquired a majority stake in AQCF Group

CARSO Group, a leading provider of testing services, has acquired a majority stake in AQCF Group, a key player in the field of food safety.

Mehr erfahren
Prestige Inhome Care has found a long-term strategic partner
Healthcare

Prestige Inhome Care has found a long-term strategic partner

Prestige Inhome Care has received a growth capital investment from Yorkway Private. The newly formed partnership will provide growth capital for geographic expansion, increasing Prestige’s range of services and potential future acquisitions. The investment in Prestige is in line with Yorkway’s mandate to invest in leading Australian mid-market companies with strong management teams, backed by significant growth tail winds, as is the case in the aged care industry.

Mehr erfahren
Cara Care wurde von Mahana Therapeutics übernommen
Private Equity | Healthcare | TMT

Cara Care wurde von Mahana Therapeutics übernommen

Mahana Therapeutics Inc., ein innovativer Anbieter von digitalen Gesundheitslösungen für chronische Erkrankungen, hat die Übernahme von Cara Care (HiDoc Technologies GmbH) abgeschlossen. Cara Care ist eine führende digitale Gesundheitsplattform und eine offizielle digitale Gesundheitsanwendung (DiGA) zur Verbesserung der Darmgesundheit. Diese Übernahme, die auch von den Investoren Lux Capital und Jazz Ventures Partners unterstützt wird, passt perfekt zur Expansionsstrategie von Mahana.

Mehr erfahren